106190 — High Tech Pharm Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩181bn
- KR₩183bn
- KR₩77bn
- 55
- 39
- 65
- 54
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 10,331 | 1,038 | 12,637 | 7,880 | 5,365 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 17,875 | 19,708 | 9,472 | 28,555 | 24,483 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 39,024 | 40,477 | 40,488 | 52,040 | 56,571 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 89,944 | 85,205 | 80,544 | 74,934 | 75,001 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 131,725 | 128,446 | 122,937 | 132,202 | 135,058 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 25,554 | 26,933 | 22,703 | 31,738 | 22,785 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 33,141 | 33,302 | 29,052 | 32,263 | 28,064 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 98,584 | 95,144 | 93,885 | 99,939 | 106,994 |
Total Liabilities & Shareholders' Equity | 131,725 | 128,446 | 122,937 | 132,202 | 135,058 |
Total Common Shares Outstanding |